US equities
|
MU
$1,029.00
▼-0.66%
NVDA
$229.28
▼-0.52%
SPCX
$162.57
▲+1.25%
TSLA
$382.70
▲+2.05%
AAPL
$336.64
▼-1.11%
MSFT
$535.07
▲+2.38%
AMZN
$262.43
▲+3.29%
META
$718.67
▼-0.31%
MU
$1,029.00
▼-0.66%
NVDA
$229.28
▼-0.52%
SPCX
$162.57
▲+1.25%
TSLA
$382.70
▲+2.05%
AAPL
$336.64
▼-1.11%
MSFT
$535.07
▲+2.38%
AMZN
$262.43
▲+3.29%
META
$718.67
▼-0.31%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Patrick Cournoyer
Recent news which mentions Patrick Cournoyer
EXCLUSIVE: FDA Advisors Say Regulatory Certainty Needed For Cannabis Market
September 28, 2023
Tickers
CBD
CCC
Tags
CCC
Interview
Exclusives
From
Benzinga
FDA Presents Potential Framework For CBD, From Edibles To Delta-8, Reaffirms Congress Is In Charge
May 30, 2023
Tickers
JAZZ
Tags
Patrick Cournoyer
Norman Birenbaum
JAZZ
From
Benzinga
FDA Considers Regulating CBD In Foods & Supplements, Plans To Study Pregnancy And Daily Use
December 27, 2022
Tags
Kathleen Rice
Markets
Morgan Griffith
From
Benzinga
Johnson & Johnson Urges FDA To Take Interim Steps As It Continues To Review CBD
June 16, 2022
Tickers
CBD
HEMP
JNJ
Tags
JNJ
Legal
Cannabis Wire
From
Benzinga